https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-09 / Cancer Res. 2011 Apr;71(7):2497-506
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-09 / Cancer Res. 2011 Apr;71(7):2497-5062011-02-09 00:00:002019-02-15 08:51:29IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-03 / Clin. Cancer Res. 2011 Apr;17(8):2474-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-03 / Clin. Cancer Res. 2011 Apr;17(8):2474-832011-02-03 00:00:002019-02-15 08:48:16Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-01 / J. Immunol. 2011 Feb;186(3):1325-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-01 / J. Immunol. 2011 Feb;186(3):1325-312011-02-01 00:00:002019-02-15 08:40:08Recent developments in cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-28 / Expert Opin Biol Ther 2011 Apr;11(4):441-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-28 / Expert Opin Biol Ther 2011 Apr;11(4):441-52011-01-28 00:00:002019-02-15 08:52:18Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-18 / Am. J. Reprod. Immunol. 2011 Jun;65(6):597-609
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-18 / Am. J. Reprod. Immunol. 2011 Jun;65(6):597-6092011-01-18 00:00:002019-02-15 08:40:09Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-72011-01-01 00:00:002019-02-15 08:45:50[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-62011-01-01 00:00:002019-02-15 08:50:46Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Drugs 2011 Jan;71(1):101-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Drugs 2011 Jan;71(1):101-82011-01-01 00:00:002019-02-15 08:52:53Sipuleucel-T: in metastatic castration-resistant prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-672011-01-01 00:00:002019-02-15 08:46:39New perspectives in glioma immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-20 / Clin. Dev. Immunol. 2010;2010:565643
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-20 / Clin. Dev. Immunol. 2010;2010:5656432010-12-20 00:00:002019-02-15 08:40:10Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy
